2017
DOI: 10.1016/j.bpc.2016.11.008
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of oncogene-induced genomic instability

Abstract: Activating mutations in oncogenes promote uncontrolled proliferation and malignant transformation. Approximately 30% of human cancers carry mutations in the RAS oncogene. Paradoxically, expression of mutant constitutively active Ras protein in primary human cells results in a premature proliferation arrest known as oncogene-induced senescence (OIS). This is more commonly observed in human pre-neoplasia than in neoplastic lesions, and is considered a tumor suppressor mechanism. Senescent cells are still metabol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 118 publications
0
8
0
1
Order By: Relevance
“…This may also explain why both DDR and autophagy activation appear to largely coincide in the early clinical lesions that we examined by immunohistochemistry, as these tissues, despite being collected from radio/chemotherapy-naive patients, were obviously obtained weeks, months or even years after the initial oncogenic event in vivo. Notably, our functional cell culture data are based on parallel analyses of several human cellular models and experiments with three different oncogenes commonly implicated in both pathogenesis and triggering of RS in a range of human cancers: H-Ras, c-Myc and cyclin E [45,[51][52][53]. While the precise kinetics of autophagy induction was, to some extent, oncogenedependent, the overall pattern of DDR signalling preceding an autophagy flux increase was shared by all models used.…”
Section: Discussionmentioning
confidence: 99%
“…This may also explain why both DDR and autophagy activation appear to largely coincide in the early clinical lesions that we examined by immunohistochemistry, as these tissues, despite being collected from radio/chemotherapy-naive patients, were obviously obtained weeks, months or even years after the initial oncogenic event in vivo. Notably, our functional cell culture data are based on parallel analyses of several human cellular models and experiments with three different oncogenes commonly implicated in both pathogenesis and triggering of RS in a range of human cancers: H-Ras, c-Myc and cyclin E [45,[51][52][53]. While the precise kinetics of autophagy induction was, to some extent, oncogenedependent, the overall pattern of DDR signalling preceding an autophagy flux increase was shared by all models used.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, mutation of SMC5 also leads to abnormal distribution of condensin along chromosomes with decreased condensin accumulation at pericentromeric regions and enrichment of condensin on chromosome arms in mouse embryonic stem cells (mESCs) [74]. There are complex chromatin reorganizations in senescent cells [75][76][77]. Recently, different models of SMC complex function have been presented [78][79][80].…”
Section: Future Perspectives Of Human Condensins In Cellular Senescencementioning
confidence: 99%
“… 15 Therefore, various mutations in the cells accumulate in succession, resulting in oncogene activation and inactivation of tumour suppressor genes. 16 Sustained stimulation of chronic inflammation can cause immune tolerance in the body and mutant cells cannot be identified and cleared in time. 17 The combination of the above factors ultimately leads to the inevitable occurrence of tumours.…”
Section: Inflammation and Tumour Developmentmentioning
confidence: 99%